Trimethylamine N-oxide ameliorates hepatic damage including reduction of hepatic bile acids and cholesterol in Fxr -null mice
- 1 May 2024
- journal article
- research article
- Published by Taylor & Francis in International Journal of Food Sciences and Nutrition
- Vol. 75 (4) , 1-11
Abstract
There are conflicting animal experiments on the effect of trimethylamine N-oxide (TMAO), the dietary metabolite, on non-alcoholic fatty liver disease (NAFLD). This study aims to determine the effect of TMAO on NAFLD. A diet containing 0.3% TMAO was fed to farnesoid X receptor (Fxr)-null mice, a model of NAFLD, for 13 weeks. Fxr-null mice fed TMAO showed significant reductions in liver damage markers but not wild-type mice. Hepatic bile acid and cholesterol levels were significantly decreased, and triacylglycerol levels tended to decrease in TMAO-fed Fxr-null mice. Changes in mRNA levels of hepatic bile acid and cholesterol transporters and synthetic enzymes were observed, which could explain the decreased hepatic bile acid and cholesterol levels in Fxr-null mice given the TMAO diet but not in the wild-type mice. These results suggest that TMAO intake ameliorates liver damage in Fxr-null mice, further altering bile acid/cholesterol metabolism in an FXR-independent manner.Keywords
Funding Information
- Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (3)
This publication has 41 references indexed in Scilit:
- Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction2022
- The Influence of Animal- or Plant-Based Diets on Blood and Urine Trimethylamine-N-Oxide (TMAO) Levels in HumansCurrent Nutrition Reports, 2022
- Cholesterol-lowering effects of taurine through the reduction of ileal FXR signaling due to the alteration of ileal bile acid compositionAmino Acids, 2021
- New targets for NAFLDJHEP Reports, 2021
- Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population studyAmerican Heart Journal, 2021
- Trimethylamine N‐Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver DiseaseMolecular Nutrition & Food Research, 2019
- Microbial-Host Co-metabolites Are Prodromal Markers Predicting Phenotypic Heterogeneity in Behavior, Obesity, and Impaired Glucose ToleranceCell Reports, 2017
- FXR signaling in the enterohepatic systemMolecular and Cellular Endocrinology, 2013
- Beyond reasonable doubt: Who is the culprit in lipotoxicity in NAFLD/NASH?Hepatology, 2012
- Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: Another piece of the puzzleHepatology, 2007